BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total operating revenue | 30.40%356.63M | 21.75%1B | 17.74%790.53M | 13.18%600.14M | 13.83%273.49M | -12.95%823.32M | -16.43%671.41M | -16.60%530.26M | -27.23%240.26M | 12.27%945.8M |
Operating revenue | 30.40%356.63M | 21.75%1B | 17.74%790.53M | 13.18%600.14M | 13.83%273.49M | -12.95%823.32M | -16.43%671.41M | -16.60%530.26M | -27.23%240.26M | 12.27%945.8M |
Other operating revenue | ---- | 340.25%8.62M | ---- | 939.74%4.18M | ---- | 146.43%1.96M | ---- | 35.75%402.24K | ---- | 135.80%794.25K |
Total operating cost | 22.19%247.83M | 20.23%791.46M | 17.05%608.3M | 12.30%440.8M | 15.32%202.82M | -4.72%658.31M | -8.15%519.68M | -10.53%392.52M | -24.33%175.88M | 13.94%690.95M |
Operating cost | 29.41%218.14M | 21.96%664.34M | 16.35%511.49M | 10.48%376.89M | 13.00%168.56M | -9.14%544.72M | -14.33%439.62M | -16.31%341.14M | -28.88%149.17M | 16.21%599.55M |
Operating tax surcharges | -10.96%1.23M | 3.17%8.95M | 9.59%6.08M | 21.11%4.42M | 37.96%1.38M | -9.87%8.67M | 4.37%5.55M | 58.03%3.65M | 10.06%1M | 59.26%9.62M |
Operating expense | -20.54%5.01M | 23.06%24.39M | 8.31%16.85M | 15.41%11.86M | 31.57%6.3M | 42.33%19.82M | 49.57%15.55M | 38.16%10.27M | -5.52%4.79M | 20.53%13.93M |
Administration expense | -15.76%17.2M | 20.35%70.74M | 19.51%49.86M | 23.64%34.4M | 52.65%20.41M | 18.17%58.78M | 10.17%41.72M | 13.46%27.83M | 28.90%13.37M | 15.18%49.74M |
Financial expense | -118.20%-3.36M | -43.42%-13.45M | 87.63%-985.15K | 57.85%-3.13M | -109.48%-1.54M | 42.75%-9.38M | 67.78%-7.97M | 58.21%-7.43M | -2,077.48%-734.17K | -17,277.92%-16.38M |
-Interest expense (Financial expense) | -38.05%251.54K | 121.98%2.69M | 283.66%2.25M | 395.77%1.91M | 554.82%406.04K | 327.59%1.21M | 1,554.84%586.22K | --385.51K | --62.01K | 1,707.79%283.82K |
-Interest Income (Financial expense) | 57.62%-1.01M | 25.72%-6.3M | -10.93%-6.02M | -12.53%-4.43M | -47.29%-2.39M | -158.97%-8.48M | -195.13%-5.43M | -172.24%-3.94M | -101.89%-1.62M | 26.09%-3.28M |
Research and development | 24.85%9.61M | 2.24%36.48M | -0.79%25.01M | -4.13%16.36M | -6.93%7.7M | 3.48%35.68M | 6.13%25.21M | 16.81%17.07M | 31.43%8.27M | 16.42%34.48M |
Credit Impairment Loss | -31.82%-6.44M | 63.57%-4.42M | -3,850.45%-1.79M | 4.09%-6.68M | -48.18%-4.89M | -3,773.68%-12.13M | -127.24%-45.38K | -60.18%-6.97M | 36.94%-3.3M | 125.11%330.22K |
Asset Impairment Loss | -688.33%-4.61M | -154.44%-10.27M | -27.18%-1.9M | -169.13%-2.03M | -2.38%-584.36K | 78.38%-4.03M | -119.12%-1.5M | -280.79%-755.28K | -142.80%-570.77K | -868.96%-18.66M |
Other net revenue | 113.36%3.08M | 165.84%11.51M | 256.32%7.78M | -963.46%-38.3M | -306.15%-23.03M | -15.19%-17.48M | 64.74%-4.97M | -183.65%-3.6M | 5,043.74%11.17M | -194.77%-15.18M |
Fair value change income | 133.85%10.07M | 95.43%-539.37K | -51.60%-14.27M | -730.53%-44.14M | -516.78%-29.76M | -88.68%-11.79M | 57.02%-9.42M | -65.88%-5.31M | 260.63%7.14M | 4.73%-6.25M |
Invest income | -122.80%-2.73M | 273.62%25.2M | 356.06%24.78M | 49.69%13.7M | 55.15%11.98M | -16.77%6.75M | -30.67%5.43M | 49.37%9.15M | 148.38%7.72M | -67.80%8.1M |
Asset deal income | 250.60%188.1K | 17.28%118.78K | 2.86%145.11K | 10,655.63%181.69K | 289.28%53.65K | 14.74%101.28K | 191.65%141.07K | 101.10%1.69K | --13.78K | 773.96%88.27K |
Other revenue | 3,832.77%6.6M | -61.09%1.41M | 101.21%823.41K | 139.13%684.7K | 2.63%167.72K | 200.21%3.63M | -35.50%409.24K | -44.03%286.33K | 9.18%163.41K | 82.41%1.21M |
Operating profit | 134.83%111.88M | 50.75%222.4M | 29.47%190.01M | -9.76%121.05M | -36.94%47.64M | -38.45%147.52M | -34.36%146.76M | -31.49%134.14M | -22.50%75.55M | -4.91%239.68M |
Add:Non operating Income | 232.19%187.18K | -84.37%337.48K | -90.05%480.68K | -97.80%72.94K | -95.74%56.35K | -82.05%2.16M | -54.46%4.83M | -64.29%3.31M | -69.61%1.32M | 166.69%12.03M |
Less:Non operating expense | -60.94%457.45K | 97.88%3.29M | 230.66%1.85M | 205.75%1.25M | 263,710.57%1.17M | -69.24%1.66M | -77.80%559.1K | -6.10%409.83K | -99.92%443.95 | 493.14%5.4M |
Total profit | 139.88%111.61M | 48.25%219.45M | 24.90%188.64M | -12.53%119.87M | -39.47%46.53M | -39.90%148.02M | -34.80%151.03M | -33.03%137.03M | -24.10%76.87M | -3.65%246.3M |
Less:Income tax cost | 171.49%15.12M | 49.73%29.71M | 16.17%23.96M | -20.56%15.34M | -45.75%5.57M | -47.10%19.84M | -39.43%20.62M | -36.29%19.31M | -29.65%10.27M | 3.83%37.51M |
Net profit | 135.58%96.49M | 48.03%189.74M | 26.28%164.68M | -11.21%104.52M | -38.51%40.96M | -38.61%128.18M | -34.01%130.41M | -32.47%117.72M | -23.16%66.61M | -4.88%208.79M |
Net profit from continuing operation | 135.58%96.49M | 48.03%189.74M | 26.28%164.68M | -11.21%104.52M | -38.51%40.96M | -38.61%128.18M | -34.01%130.41M | -32.47%117.72M | -23.16%66.61M | -4.88%208.79M |
Less:Minority Profit | -79.11%478.47K | 284.41%4.61M | 157.55%1.87M | 235.43%3.79M | 480.50%2.29M | 40.21%-2.5M | -98.21%-3.25M | -62,535.86%-2.8M | -135.26%-601.81K | -3,967,564.39%-4.18M |
Net profit of parent company owners | 148.29%96.01M | 41.67%185.13M | 21.81%162.81M | -16.42%100.73M | -42.46%38.67M | -38.64%130.68M | -32.92%133.66M | -30.86%120.52M | -20.91%67.21M | -2.98%212.97M |
Earning per share | ||||||||||
Basic earning per share | 142.86%0.68 | 43.48%1.32 | 23.40%1.16 | -15.29%0.72 | -40.43%0.28 | -38.67%0.92 | -33.33%0.94 | -30.89%0.85 | -44.05%0.47 | -36.71%1.5 |
Diluted earning per share | 142.86%0.68 | 43.48%1.32 | 23.40%1.16 | -15.29%0.72 | -40.43%0.28 | -38.67%0.92 | -33.33%0.94 | -30.89%0.85 | -44.05%0.47 | -36.71%1.5 |
Other composite income | 6.05K | |||||||||
Other composite income of parent company owners | ---- | ---- | ---- | ---- | ---- | ---- | --6.05K | ---- | ---- | ---- |
Total composite income | 135.58%96.49M | 48.03%189.74M | 26.28%164.68M | -11.21%104.52M | -38.51%40.96M | -38.61%128.18M | -34.00%130.41M | -32.47%117.72M | -23.16%66.61M | -4.88%208.79M |
Total composite income of parent company owners | 148.29%96.01M | 41.67%185.13M | 21.80%162.81M | -16.42%100.73M | -42.46%38.67M | -38.64%130.68M | -32.92%133.67M | -30.86%120.52M | -20.91%67.21M | -2.98%212.97M |
Total composite income of minority owners | -79.11%478.47K | 284.41%4.61M | 157.55%1.87M | 235.43%3.79M | 480.50%2.29M | 40.21%-2.5M | -98.21%-3.25M | -62,535.86%-2.8M | -135.26%-601.81K | -3,967,564.39%-4.18M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.